A child of three and a half comes to clinic after the screening at the outpatient clinic "did not match up" in one eye. No glasses have been prescribed yet. The fundus is quiet. The parents ask two things at once: "is this for life?" and "do we need to patch?". Both questions sound like a request for a prescription. In fact they are a request for a mechanism.
This course teaches you to answer such questions not with a slogan but with a distinction. Amblyopia is not a "lazy eye" in the everyday-metaphor sense, nor a diagnosis made from a single number on a chart. It is a neurodevelopmental disorder of central processing of the visual signal: a reduction in best-corrected visual acuity (BCVA) in a structurally relatively intact eye — or a reduction that cannot be fully explained by the structural abnormality found. The definition and this caveat belong to the Amblyopia Preferred Practice Pattern of the American Academy of Ophthalmology. The journal publication of the full text appeared online on 14 December 2022 and in Ophthalmology in March 2023, volume 130, pages P136–P178 (Cruz et al., PMID 36526450). The current text on the AAO website as of September 2026 is titled "Amblyopia PPP 2022 – Updated 2024": it is the same document with the February 2024 revision, not a new volume. From here on the course calls it AAO Amblyopia PPP 2022 (Updated 2024); where the journal pagination without the update is specifically meant, this is stated separately.
What the programme covers. After the course a student or resident should be able to do four things.
- Distinguish the forms of amblyopia by cause rather than by everyday severity: refractive (including bilateral isoametropic), anisometropic, strabismic, deprivation and reverse (occlusion) amblyopia. Management starts from the cause, because removing a cataract, prescribing glasses and patching the fellow eye are three different first steps.
- Explain what the critical / sensitive period of visual plasticity is and why age changes the probability of response but, under the current PPP, does not rule out an attempt at treatment, including in adolescents, especially those not previously treated.
- Put together an examination plan for a child with suspected amblyopia: history, fixation, recognition acuity with crowding, cycloplegic refraction, binocular function, exclusion of organic disease.
- Read the evidence base for the lines of treatment and put each line into one of three baskets: proven in randomised trials, promising and under investigation, not supported. In this topic the third basket is densely populated with commercial promises.
Who the course is for. Students in years 4–6 of the general medicine faculty and residents in ophthalmology and paediatrics. Knowledge of the anatomy of the visual pathway and the skills of acuity testing are assumed; the course does not replace a fundus atlas and does not teach strabismus surgery technique.
How the programme is structured. Four content modules of five lessons each. After each module there is a checkpoint of eight questions, with a pass mark of 70%. The final exam has 25 questions, a pass mark of 75% and two attempts; at least a third of the questions are case analyses. Each lesson holds one idea. The clinical cases in the lessons are generalised teaching constructs, and they are labelled as such: they are not the stories of real people.
What the programme does not cover — and this is not an oversight but a boundary.
- It does not teach how to manage a virtual patient and does not cover the drugs of the educational platform's eye panel: the platform library has no ophthalmology scenario. That is a request for separate product content, not a gap inside these lessons.
- It does not replace the surgical protocols for congenital cataract, ptosis or retinopathy of prematurity, and does not cover the technique of recession-resection. Deprivation is needed here as a cause of amblyopia and as an argument for urgency, not as a surgical course.
- It is not a guide to adults with residual amblyopia as a separate clinical-trial population: the PPP describes patients up to and including 17 years of age. Adult perceptual plasticity is mentioned as a research horizon, not as a standard of treatment.
- It does not give national thresholds of the Ministry of Health of the Republic of Kazakhstan for amblyopia: no separate current clinical protocol of the Ministry of Health of the Republic of Kazakhstan specifically on amblyopia was found. The 2015 protocol «Косоглазие у детей» [Strabismus in children] refers to the Amblyopia PPP 2012 — an edition that the AAO has since replaced. The course's numbers are therefore taken from the current AAO Amblyopia PPP 2022 (Updated 2024), from the Pediatric Eye Evaluations PPP (Table 2 with the February 2026 revision), from publications of the Pediatric Eye Disease Investigator Group (PEDIG) and from Cochrane reviews, not "from memory" and not from slide decks.
- It does not restate an observational association as an effect. The phrase "X has been shown to reduce Y" without a population and a design does not appear in this text.
Why treat at all if "the other eye can see". The PPP states the rationale directly. Timely treatment usually improves acuity, may improve binocularity and reduces the likelihood of visual disability if the fellow eye is later damaged. The lifetime risk of bilateral visual impairment in people with amblyopia is roughly doubled (references within the PPP). The retrospective data the PPP cites link some of the cases of total loss to trauma to the fellow eye. This is not a reason to frighten the family with catastrophe — it is a reason not to leave one eye functionally switched off because "for now the other one is fine".
One more boundary worth naming in the very first hour. Amblyopia often coexists with strabismus and refractive error, but treating amblyopia and strabismus surgery are different tasks. Aligning the eyes without dealing with acuity, and "curing the acuity with patching" without removing the deprivation, are two typical errors of different specialties. The course keeps to the optical and occlusion logic; it leaves surgery to adjacent modules.
If after this introduction you are left feeling that "amblyopia is just patching", Module 1 is precisely about why that feeling is clinically costly.